Healthcare Triangle, Inc. Announces Nasdaq Hearings Panel's Grant of the Company's Request for Continued Listing of Its Securities

About this update from Healthcare Triangle, Inc.

[{"type":"image","caption":"","headline":"Healthcare Triangle Announces Warrant Inducement for Aggregate Gross Proceeds of Approximately $478,000","size":{"original":{"width":140,"height":180,"url":"https://media.zenfs.com/en/newsmediawire_165/c6a969a9e826971ee27b1cf8545c350c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Ul_S4nhMSQh3E.wJ26qOtw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTI3MDtjZj13ZWJw/https://media.zenfs.com/en/newsmediawire_165/c6a969a9e826971ee27b1cf8545c350c","width":140,"height":180}}},{"type":"text","content":"PLEASANTON, CALIFORNIA - July 7, 2025 (NEWMEDIAWIRE) - Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a visionary leader in digital transformation solutions for the healthcare and life sciences industries, today announced that the Nasdaq Stock Market (or "Nasdaq") Hearings Panel (or "the Company's Panel") has granted the company's request for its continued listing of the Company's securities on the Nasdaq. This decision followed a review of a Public Interest Concern raised by Nasdaq's Listing Qualifications Department.","length":601,"tagName":"p"},{"type":"text","content":"After careful consideration, the Panel determined that Healthcare Triangle Inc. is in compliance with Nasdaq's shareholders' equity rule and granted the Company a continued listing exception to resolve previously noted deficiencies. The Panel will impose a Discretionary Panel Monitor for a one-year period following any compliance determination.","length":354,"tagName":"p"},{"type":"text","content":"The Panel granted the Company's request for continued listing on the Exchange, subject to the following:","length":108,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"On or before August 8, 2025, the Company must effect a reverse stock split at a ratio sufficient to achieve and maintain long-term compliance with the Bid Price Rule and notify the Panel that it has done so; and","length":211,"tagName":"p"}]},{"val":[{"type":"text","content":"On or before September 5, 2025, the Company must demonstrate compliance with the Bid Price Rule by maintaining a $1 closing bid price for a minimum of twenty consecutive trading days.","length":183,"tagName":"p"}]}],"tagName":"ol","bulletedList":false,"length":394},{"type":"text","content":""We are elated and gra...

More updates from Healthcare Triangle, Inc.